The bone-derived skeletal growth factor (SGF), jointly developed by a research 
facility under the direction of leading biochemist, academician and researcher 
Zhao Yufen and the Anhui-based research center of one of the world's health 
industry leaders People's GuoTai Group (PGTG), broke through the formula 
stability bottleneck after unremitting efforts over the last three years and 
brought new hope for bone health. It is the world's only healthcare supplement 
that provides protection against diseases of the skeletal system, and the only 
dietary health product that can supplement calcium without side effects, 
improve bone density, strengthen bones, lubricate bone joints and regenerate 
cartilage.

The GuoTai SGF bone-derived factor is the first to resolve the stability issue, 
and was finally released after tens of thousands of iterations until just the 
right formulation was achieved: a finely-tuned combination of PGTG's patented 
small molecule yak bone collagen peptide to add to bone density and strengthen 
the bone, PGTG's patented cartilage peptide for bone joint lubrication, and 
chitosan oligosaccharide, a.k.a. the "sixth essential element of the body", to 
promote cartilage regeneration, as well as milk mineral salts that further 
enhance bone density. It is the only integrated product in the world that can 
simultaneously offer everything that is needed for bone health in one 
formulation: supplement calcium, improve bone density, strengthen the bone, 
lubricate the joints, and regenerate cartilage.

With several features proprietary to PGTG, the GuoTai SGF bone-derived factor 
can regulate bone metabolism and promote bone growth. The superior product is a 
result of PGTG's three years of work and has delivered a formulation that, for 
the first time, includes just the right combination of chitosan 
oligosaccharide, yak bone peptide and milk mineral salt and maintains full 
stability after tens of thousands of tests.


SOURCE: Anhui Guotai Biotechnology Co.,Ltd.